These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6357078)
1. Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections. Nakazawa H; Hashimoto T; Nishiura T; Mitsuhashi S Antimicrob Agents Chemother; 1983 Sep; 24(3):437-9. PubMed ID: 6357078 [TBL] [Abstract][Full Text] [Related]
2. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation. Brumfitt W; Hamilton-Miller JM; Dixson S; Gargan RA; Gooding A J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436 [TBL] [Abstract][Full Text] [Related]
3. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase]. Prát V; Horcicková M; Hatala M; Liska M; Matousovic K Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692 [No Abstract] [Full Text] [Related]
4. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects. Weber DJ; Tolkoff-Rubin NE; Rubin RH Pharmacotherapy; 1984; 4(3):122-36. PubMed ID: 6739312 [TBL] [Abstract][Full Text] [Related]
5. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals. Legrand P; Fournier G; Buré A; Jarlier V; Nicolas MH; Decré D; Duval J; Philippon A Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):527-9. PubMed ID: 2504594 [TBL] [Abstract][Full Text] [Related]
6. Augmentin therapy in the treatment of urinary tract infections in general practice. Abbas AM; Goel PK; Venkit N; Gowers E Br J Clin Pract; 1984 Feb; 38(2):49-51. PubMed ID: 6704296 [No Abstract] [Full Text] [Related]
7. [Treatment of urinary infection with a combination of amoxycillin and clavulanic acid]. Vránková J; Kocvara R Cas Lek Cesk; 1983 Sep; 122(37):1144-5. PubMed ID: 6627336 [No Abstract] [Full Text] [Related]
11. Augmentin (amoxycillin-clavulanic acid) compared with co-trimoxazole in urinary tract infections. Fancourt GJ; Matts SG; Mitchell CJ Br Med J (Clin Res Ed); 1984 Jul; 289(6437):82-3. PubMed ID: 6428687 [No Abstract] [Full Text] [Related]
12. Amoxicillin-clavulanate (Clavulin). Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Infectious Diseases and Immunization Committee CMAJ; 1985 Oct; 133(8):739. PubMed ID: 4042055 [No Abstract] [Full Text] [Related]
13. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections. Tan TH; Tay L; Yeo M; Feng PH Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995 [No Abstract] [Full Text] [Related]
14. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]. Sunakawa K; Ishizuka Y Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075 [TBL] [Abstract][Full Text] [Related]
15. Complementary activity of mezlocillin and the combination of amoxicillin with clavulanic acid on Enterobacteriaceae. Roy C; Foz A; Tirado M; Fuster C; Segura C Infection; 1982; 10 Suppl 3():S262-6. PubMed ID: 6218121 [TBL] [Abstract][Full Text] [Related]
16. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections]. Hoshina H; Hirosawa H; Mikuni K; Ichihashi H Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520 [TBL] [Abstract][Full Text] [Related]
17. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin. Stobberingh EE J Antimicrob Chemother; 1988 Jan; 21(1):9-16. PubMed ID: 3128523 [TBL] [Abstract][Full Text] [Related]
18. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase. Bush K; Flamm RK; Ohringer S; Singer SB; Summerill R; Bonner DP Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases. Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052 [TBL] [Abstract][Full Text] [Related]
20. Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin. Brumfitt W; Hamilton-Miller JM Br J Clin Pract; 1985 Sep; 39(9):346-51. PubMed ID: 3904797 [No Abstract] [Full Text] [Related] [Next] [New Search]